In 2023, the Cochrane Breast Cancer Group facilitated the publication of 6 reviews. These included:

1. Psychological interventions for women with non-metastatic breast cancer

2. Skin-sparing mastectomy for the treatment of breast cancer

3. Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk

4. Training health workers in clinical breast examination for early detection of breast cancer in low- and middle-income countries

5. Postmastectomy radiotherapy for women with early breast cancer and one to three positive lymph nodes

6. Platinum-based chemotherapy for early triple-negative breast cancer

In 2024, the Group continues to work on reviews with author teams on topics deemed relevant to consumers and health practitioners.